Review



development egfr signaling via small gtpases pathway  (GeneGo Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GeneGo Inc development egfr signaling via small gtpases pathway
    Top 20 Proteins from the 196 Tumor Unique Proteins from the <t> ERBB2+ </t> Gastric Cancer Sample Set
    Development Egfr Signaling Via Small Gtpases Pathway, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/development egfr signaling via small gtpases pathway/product/GeneGo Inc
    Average 90 stars, based on 1 article reviews
    development egfr signaling via small gtpases pathway - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues"

    Article Title: Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues

    Journal: Journal of proteome research

    doi: 10.1021/acs.jproteome.5b00827

    Top 20 Proteins from the 196 Tumor Unique Proteins from the ERBB2+ Gastric Cancer Sample Set
    Figure Legend Snippet: Top 20 Proteins from the 196 Tumor Unique Proteins from the ERBB2+ Gastric Cancer Sample Set

    Techniques Used: Over Expression, Binding Assay, Expressing, Biomarker Discovery, Marker

    ERBB signaling pathway analysis. (a) Summation of the RNA-Seq and proteomic values for genes present in the ERBB signaling pathway from KEGG.34 Red circle: RNA-Seq ≥1 cutoff value. (The red box means the RPKM value is higher than the cut off. The red color is selected only for better clarity. Note this is a different format for visual clarity as the red circles provid best contrast with the green boxes used in the KEGG figures.) Blue cross = RNA-Seq <1. Blue star = proteomics spectral count value >0. Yellow box = proteomics spectral count value >3 only in ERBB2+ tumor sample. (b) Simplified ERBB signaling pathway that lists only the subpathways with a high number of protein observations (ERBB2+ vs ERBB2− patient samples). All genes illustrated have RPKM value >1, green box: spectral counts ≥1; the red star: higher spectral counts in ERBB2+ set (also spectral counts in tumor is higher than control). Note that color is selected only for visual clarity.
    Figure Legend Snippet: ERBB signaling pathway analysis. (a) Summation of the RNA-Seq and proteomic values for genes present in the ERBB signaling pathway from KEGG.34 Red circle: RNA-Seq ≥1 cutoff value. (The red box means the RPKM value is higher than the cut off. The red color is selected only for better clarity. Note this is a different format for visual clarity as the red circles provid best contrast with the green boxes used in the KEGG figures.) Blue cross = RNA-Seq <1. Blue star = proteomics spectral count value >0. Yellow box = proteomics spectral count value >3 only in ERBB2+ tumor sample. (b) Simplified ERBB signaling pathway that lists only the subpathways with a high number of protein observations (ERBB2+ vs ERBB2− patient samples). All genes illustrated have RPKM value >1, green box: spectral counts ≥1; the red star: higher spectral counts in ERBB2+ set (also spectral counts in tumor is higher than control). Note that color is selected only for visual clarity.

    Techniques Used: RNA Sequencing, Control



    Similar Products

    development egfr signaling via small gtpases pathway  (GeneGo Inc)
    90
    GeneGo Inc development egfr signaling via small gtpases pathway
    Top 20 Proteins from the 196 Tumor Unique Proteins from the <t> ERBB2+ </t> Gastric Cancer Sample Set
    Development Egfr Signaling Via Small Gtpases Pathway, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/development egfr signaling via small gtpases pathway/product/GeneGo Inc
    Average 90 stars, based on 1 article reviews
    development egfr signaling via small gtpases pathway - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Top 20 Proteins from the 196 Tumor Unique Proteins from the ERBB2+ Gastric Cancer Sample Set

    Journal: Journal of proteome research

    Article Title: Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues

    doi: 10.1021/acs.jproteome.5b00827

    Figure Lengend Snippet: Top 20 Proteins from the 196 Tumor Unique Proteins from the ERBB2+ Gastric Cancer Sample Set

    Article Snippet: On the basis of the oncogene list information, for ERBB2+ gastric cancer set, four pathways, namely, ERBB family signaling, development EGFR signaling via small GTPases, development EGFR signaling, and cytoskeleton remodeling integrin outside-in signaling pathway from the GeneGo database, 33 were examined for integration of the proteomic and transcriptomic data and are listed in Supplementary Figure S-4 (a–d).

    Techniques: Over Expression, Binding Assay, Expressing, Biomarker Discovery, Marker

    ERBB signaling pathway analysis. (a) Summation of the RNA-Seq and proteomic values for genes present in the ERBB signaling pathway from KEGG.34 Red circle: RNA-Seq ≥1 cutoff value. (The red box means the RPKM value is higher than the cut off. The red color is selected only for better clarity. Note this is a different format for visual clarity as the red circles provid best contrast with the green boxes used in the KEGG figures.) Blue cross = RNA-Seq <1. Blue star = proteomics spectral count value >0. Yellow box = proteomics spectral count value >3 only in ERBB2+ tumor sample. (b) Simplified ERBB signaling pathway that lists only the subpathways with a high number of protein observations (ERBB2+ vs ERBB2− patient samples). All genes illustrated have RPKM value >1, green box: spectral counts ≥1; the red star: higher spectral counts in ERBB2+ set (also spectral counts in tumor is higher than control). Note that color is selected only for visual clarity.

    Journal: Journal of proteome research

    Article Title: Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues

    doi: 10.1021/acs.jproteome.5b00827

    Figure Lengend Snippet: ERBB signaling pathway analysis. (a) Summation of the RNA-Seq and proteomic values for genes present in the ERBB signaling pathway from KEGG.34 Red circle: RNA-Seq ≥1 cutoff value. (The red box means the RPKM value is higher than the cut off. The red color is selected only for better clarity. Note this is a different format for visual clarity as the red circles provid best contrast with the green boxes used in the KEGG figures.) Blue cross = RNA-Seq <1. Blue star = proteomics spectral count value >0. Yellow box = proteomics spectral count value >3 only in ERBB2+ tumor sample. (b) Simplified ERBB signaling pathway that lists only the subpathways with a high number of protein observations (ERBB2+ vs ERBB2− patient samples). All genes illustrated have RPKM value >1, green box: spectral counts ≥1; the red star: higher spectral counts in ERBB2+ set (also spectral counts in tumor is higher than control). Note that color is selected only for visual clarity.

    Article Snippet: On the basis of the oncogene list information, for ERBB2+ gastric cancer set, four pathways, namely, ERBB family signaling, development EGFR signaling via small GTPases, development EGFR signaling, and cytoskeleton remodeling integrin outside-in signaling pathway from the GeneGo database, 33 were examined for integration of the proteomic and transcriptomic data and are listed in Supplementary Figure S-4 (a–d).

    Techniques: RNA Sequencing, Control